Skip to main content

Table 2 Effects of Turmeric on Serum Levels of Liver Enzymes in Patients with NAFLD

From: The effect of turmeric on lipid profile, malondialdehyde, liver echogenicity and enzymes among patients with nonalcoholic fatty liver disease: a randomized double blind clinical trial

Variables Placebo, n = 32 Turmeric, n = 32 P1a
FBS (mg/dL)
 Before 100.70 ± 12.62 105.16 ± 12.85 0.167
 After 97 ± 10.94 101.08 ± 10.51 0.134
 P2b 0.002 0.060  
ALT (U/L)
 Before 35.42 ± 18.51 39.56 ± 22.41 0.424
 After 39.50 ± 21.15 30.51 ± 12.61 0.043
 P2 0.307 0.038  
AST (U/L)
 Before 27.29 ± 11.53 26.81 ± 10.54 0.861
 After 25.26 ± 9.66 21.19 ± 5.67 0.044
 P2 0.303 0.021  
GGT(U/L)
 Before 32.91 ± 20.26 33.81 ± 17.50 0.767
 After 31.59 ± 16.70 25.62 ± 9.88 0.046
 P2 0.562 0.000  
AST/ALT ratio
 Before 0.829 ± 0.23 0.744 ± 0.23 0.146
 After 0.763 ± 0.05 0.773 ± 0.21 0.887
 P2 0.198 0.449  
  1. Values presented as mean ± SD
  2. α analyzed by Pearson χ2, β analyzed by Fisher’s exact-test), NAFLD nonalcoholic fatty liver disease, FBS fasting blood sugar, AST aspartate aminotransferase, ALT alanine aminotransferase, GGT gamma glutamyl transpeptidase
  3. a,bP values indicate differences between the intervention and placebo groups at before and after intervention (Paired T Test)